Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19

Daniel D Rhoads^{1

2}, Sree S Cherian^{3

2}, Katharine Roman³, Lisa M Stempak^{3

2}, Christine L Schmotzer^{3

2}, Navid Sadri^{3

2}

Affiliations

¹ Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA ddr26@case.edu.
² Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
³ Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

Comparative Study

Daniel D Rhoads et al. J Clin Microbiol. 2020.

. 2020 Jul 23;58(8):e00760-20.

doi: 10.1128/JCM.00760-20. Print 2020 Jul 23.

Daniel D Rhoads^{1

2}, Sree S Cherian^{3

2}, Katharine Roman³, Lisa M Stempak^{3

2}, Christine L Schmotzer^{3

2}, Navid Sadri^{3

2}

¹ Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA ddr26@case.edu.
² Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
³ Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

No abstract available

Keywords: COVID-19; SARS-CoV-2; coronavirus; emergency use authorization; in vitro diagnostic; nucleic acid amplification; virology.

References

1. Biswas B. 2016. Clinical performance evaluation of molecular diagnostic tests. J Mol Diagn 18:803–812. doi:10.1016/j.jmoldx.2016.06.008. - DOI - PubMed
1. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, Ji W. 19 February 2020. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology doi:10.1148/radiol.2020200432. - DOI - PMC - PubMed